Abiopharma

(99% Neutral) Coherus BioSciences Inc (CHRS) Files Form 8-K

(99% Positive) Aclarion Inc (ACONW) Announces Enrollment Update for partnerships Due to Patient Enrollment Issues, Regulatory Process

Vericel Announces Preliminary 2025 Financial Results and Business Updates

Femasys Announces Partnership with Refuah Health Center to Expand First-Line Access to FemaSeed® in Community-Based Care

Illumina Announces Preliminary Unaudited Financial Results for Fourth Quarter and Fiscal Year 2025

Moleculin Reports Independent Assessment Confirms No Cardiotoxicity of Annamycin in 90 Subjects

(90% Positive) Moleculin Biotech Inc. (MBRX) Announces Enrollment Update for maximum Due to Patient Enrollment Issues, Safety Review, Efficacy Assessment

(69% Neutral) Treace Medical Concepts Inc. (TMCI) Reports Q1 2026 Financial Results

Propanc Biopharma Provides Shareholder Update

LEWIS JOEL 🔴 sold 56.3K shares of GALECTIN THERAPEUTICS INC (GALT) at $3.88 Transaction Date: Jan 05, 2026 | Filing ID: 000010

(100% Positive) Biofrontera Inc. (BFRI) Reports Q1 2026 Financial Results

(70% Positive) IDEXX Laboratories Inc. (IDXX) Files Form 8-K

Biofrontera Notification (BFRI)

(75% Positive) Avita Medical Ltd (RCEL) Announces Enrollment Update for million Due to Patient Enrollment Issues, Regulatory Process

IDEXX Announces CEO Succession